[
  {
    "ts": null,
    "headline": "Jefferies says market nears short term “peak RFK negativity\", Vaccine makers up",
    "summary": "Investing.com -- Shares of Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) were up roughly 7% at $41, while those of Pfizer Inc (NYSE:PFE)were up nearly 2%. Jefferies analysts said Investor sentiment around Moderna Inc could be nearing a short-term low, amid recent concerns tied to vaccine transparency and structural issues might start to ease.",
    "url": "https://finnhub.io/api/news?id=a7935903259db8982c1fd032e4d696409a5560ea1b74e499c39bd9c023431876",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732306589,
      "headline": "Jefferies says market nears short term “peak RFK negativity\", Vaccine makers up",
      "id": 131575732,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares of Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) were up roughly 7% at $41, while those of Pfizer Inc (NYSE:PFE)were up nearly 2%. Jefferies analysts said Investor sentiment around Moderna Inc could be nearing a short-term low, amid recent concerns tied to vaccine transparency and structural issues might start to ease.",
      "url": "https://finnhub.io/api/news?id=a7935903259db8982c1fd032e4d696409a5560ea1b74e499c39bd9c023431876"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock",
    "summary": "We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this piece, we will look at where ranks on the list. With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal […]",
    "url": "https://finnhub.io/api/news?id=19cc320be19ed8303a96a3f7d423d6c8d71f27d0b39e4fb04391377fcd8a5982",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732303071,
      "headline": "Goldman Sachs: Moderna, Inc. (NASDAQ:MRNA) Is A Top Growth Investor Stock",
      "id": 131575734,
      "image": "https://s.yimg.com/ny/api/res/1.2/FqZcHrODaIrCN8kZIFGSOg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/73bd868744057cdab0c1db0e29036a96",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth. In this piece, we will look at where ranks on the list. With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal […]",
      "url": "https://finnhub.io/api/news?id=19cc320be19ed8303a96a3f7d423d6c8d71f27d0b39e4fb04391377fcd8a5982"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference",
    "summary": "Moderna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.",
    "url": "https://finnhub.io/api/news?id=2428435aed9f1c9c3e95322511ea9094d8e3ccea05dc84009fd327f08739c202",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732300363,
      "headline": "Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference",
      "id": 131575735,
      "image": "https://www.investopedia.com/thmb/ufQdpCxSx0nyCCAmiwCpL9P0Pd4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151784638-8bbd332dd5e14dc7bb50eb7cedc5e928.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna shares surged further Friday, a day after a senior executive made bullish comments at a healthcare conference about the vaccine maker's pipeline and cash position.",
      "url": "https://finnhub.io/api/news?id=2428435aed9f1c9c3e95322511ea9094d8e3ccea05dc84009fd327f08739c202"
    }
  },
  {
    "ts": null,
    "headline": "Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store",
    "summary": "Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK appointment. Click for my MRNA stock update.",
    "url": "https://finnhub.io/api/news?id=a186971be94e6075116e7eab2f5a60a76297e5fec842b0e96f1fe77dc43feff0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732273623,
      "headline": "Moderna's Fresh Blow As RFK Heads To HHS - A Tough 2025 May Be In Store",
      "id": 131566035,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182853884/image_1182853884.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc.'s stock plummets as challenges mount, including vaccine skepticism, competitive pressures, and the RFK appointment. Click for my MRNA stock update.",
      "url": "https://finnhub.io/api/news?id=a186971be94e6075116e7eab2f5a60a76297e5fec842b0e96f1fe77dc43feff0"
    }
  }
]